Mogrify Employee Directory
Biotechnology ResearchEngland, United Kingdom2-10 Employees
Mogrify is a Cambridge, UK-based biotechnology company that has developed a proprietary suite of platform technologies to guide cellular reprogramming and maintain cell identity. By leveraging large-scale data, these platforms aim to predict the transcription factors and growth factors required to generate any target human cell type from a given source cell type, supporting both in vivo reprogramming therapies and related applications. The company focuses on regenerative medicine, with potential use cases across ophthalmology, otology, metabolic diseases, and other degenerative conditions. Mogrify positions itself within the biotechnology research sector as a developer of transformative cell engineering approaches intended to advance in vivo therapies and ex vivo cell therapy development. Recent activity includes the introduction of EpiMOGRIFY, reflecting continued evolution of its platform capabilities. The company is based in Cambridge and operates with a multi-disciplinary, research-driven approach aimed at addressing high-need areas in regenerative medicine.